Alkermes (ALKS) Equity Average (2010 - 2026)
Alkermes (ALKS) reported Equity Average of $1.8 billion for Q1 2026, up 19.96% year-over-year from $1.5 billion in Q1 2025, and up 0.51% quarter-over-quarter from $1.8 billion in Q4 2025.
Alkermes (ALKS) Equity Average (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Equity Average data on file, last reported at $1.8 billion in Q1 2026.
- Equity Average for Q1 2026 came in at $1.8 billion, up 19.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 19.96% YoY), and the FY2025 annual result was $1.6 billion, up 23.11% from the prior year.
- Equity Average rose to $1.8 billion in Q1 2026 per ALKS's latest filing, from $1.8 billion in the prior quarter.
- Over five years, Equity Average peaked at $1.8 billion in Q1 2026 and troughed at $1.0 billion in Q1 2023.
- A 5-year average of $1.3 billion and a median of $1.3 billion in 2023 frame the typical range for Equity Average.
- The sharpest annual moves came in 2023 and 2025: Equity Average dropped 6.34% in 2023, then soared 30.35% in 2025.
- A 5-year view of Equity Average shows it stood at $1.0 billion in 2022, then gained by 22.6% to $1.3 billion in 2023, then rose by 7.77% to $1.4 billion in 2024, then gained by 28.86% to $1.8 billion in 2025, then rose by 0.51% to $1.8 billion in 2026.
- Business Quant data shows ALKS's Equity Average at $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 76.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.79 Bn |
| Dec 31, 2025 | 1.78 Bn |
| Sep 30, 2025 | 1.68 Bn |
| Jun 30, 2025 | 1.57 Bn |
| Mar 31, 2025 | 1.49 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Sep 30, 2024 | 1.29 Bn |
| Jun 30, 2024 | 1.27 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Sep 30, 2023 | 1.32 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 1.08 Bn |
| Mar 31, 2022 | 1.09 Bn |
| Dec 31, 2021 | 1.10 Bn |
| Sep 30, 2021 | 1.10 Bn |
| Jun 30, 2021 | 1.07 Bn |